F-group (family)
235.1.1.9 SLT
Ligands and drugs
383
Member domains
65
with ligand contacts (≤ 4 Å)
17.0% of members
59
with DrugDomain annotations
15.4% of members
32
with a DrugBank compound
8.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 235.1.1.9 belongs to X-group 235 Lysozyme-like, which binds 11.0 ligand superclasses per 20 proteins, broader than 98% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02595 | BLG | (2R,3S,5S)-2-(Hydroxymethyl)-5-[(2-sulfoethyl)carbamoyl]-3-pyrrolidiniumyl 2-acetamido-2-deoxy-4-O-sulfo-beta-D-glucopyranoside | 6 |
| DB00141 | NAG | N-Acetylglucosamine | 1 |
| DB03321 | 4AM | Des(carbamimidoyl) zanamivir | 1 |
| DB03991 | DAN | 2-deoxy-2,3-dehydro-N-acetylneuraminic acid | 1 |
| DB04227 | 9AM | 9-Amino-2-deoxy-2,3-dehydro-n-acetyl-neuraminic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| BLG | 4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)-5-METHYLHYDROXY-L-PROLINE-TAURINE | 12 |
| CL | CHLORIDE ION | 11 |
| ZNmetal | ZINC ION | 6 |
| ZIA | [(2R)-5-oxopyrrolidin-2-yl]methyl 2-acetamido-2-deoxy-beta-D-glucopyranoside | 2 |
| 3XR | (2S,3R,4S,5S)-2-(acetylamino)-5-carboxy-3,4-dihydroxypiperidinium | 1 |
| 4AM | 4-AMINO-2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID | 1 |
| 9AM | 9-AMINO-2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID | 1 |
| DAN | 2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID | 1 |
| MGmetal | MAGNESIUM ION | 1 |
| P6G | HEXAETHYLENE GLYCOL | 1 |
| PG0 | 2-(2-METHOXYETHOXY)ETHANOL | 1 |
| UL6 | [(2S)-1,4-dioxan-2-yl]methyl 2-acetamido-2-deoxy-beta-D-glucopyranoside | 1 |
| UM9 | 2,2-dimethyl-3-oxobutyl 2-acetamido-2-deoxy-beta-D-glucopyranoside | 1 |
| ZG9 | [(2S)-1,4-dioxan-2-yl]methyl 2-acetamido-2-deoxy-6-O-methyl-beta-D-glucopyranoside | 1 |
| ZH8 | ~{N}-[(2~{R},3~{R},4~{R},5~{S},6~{R})-6-(hydroxymethyl)-4,5-bis(oxidanyl)-2-[(4-oxidanylidene-3~{H}-pyrido[1,2-a]pyrimidin-2-yl)methoxy]oxan-3-yl]ethanamide | 1 |
| ZHE | cyclohexylmethyl 2-acetamido-2-deoxy-beta-D-glucopyranoside | 1 |
| ZHL | (3S,3aR,5S,6S,6aS)-2-oxohexahydro-2H-3,5-methanocyclopenta[b]furan-6-yl 2-acetamido-2-deoxy-beta-D-glucopyranoside | 1 |
| ZHR | 2-(1-benzofuran-5-yl)ethyl 2-acetamido-2-deoxy-beta-D-glucopyranoside | 1 |
| ZI2 | [(2S)-1,4-dioxan-2-yl]methyl 2-acetamido-4-amino-2,4-dideoxy-beta-D-glucopyranoside | 1 |
| ZIE | 4-nitrophenyl 2-acetamido-4-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-2-deoxy-beta-D-glucopyranoside | 1 |